Impact of metastatic status on the prognosis of EGFR mutation-positive non-small cell lung cancer patients treated with first-generation EGFR-tyrosine kinase inhibitors.
暂无分享,去创建一个
T. Kasai | A. Tamiya | S. Atagi | Y. Taniguchi | M. Kanazu | K. Okishio | K. Nakahama | Yoko Naoki | N. Omachi